The Silver Lining from COVID-19 for Clinical Trials
Former Oracle Health Sciences general manager Steve Rosenberg talked about these changes as part of a discussion on clinical trial technology in a recent EDC Clinical Leader Live event. In working with so many companies who are using Oracle Clinical One for COVID-19 related studies, Rosenberg has seen the impact of COVID-19 on trials firsthand. In many cases, companies have stopped enrolling people in existing trials or delayed new trials because COVID-19 precludes a lot of in-person clinic visits.
More Ways to Read:
🧃
Summarize
--
The key takeaways that can be read in under a minute
Sign up to unlock
Worth the squeeze
Get access to the condensed version of this piece, and every other article on The Juice, and so much more.
Start a free account on The Juice and we'll send you weekly emails sharing which podcasts, blogs, guides,
etc. are trending with other marketing or sales pros. We call it the Top 5!
Other content from
Oracle
Featured by agorapulse
